Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal versus intravenous naloxone in pediatric opioid overdose
IRCT20120629010133N7Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of naloxone in opioid intoxication (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Return of spontaneous respiration within 3 minutes. Started Apr 2023; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on IRCT20120629010133N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120629010133N7.